Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

Illumina, Inc. - Common Stock (NQ: ILMN )

84.05 -0.15 (-0.18%)
Streaming Delayed Price Updated: 4:00 PM EDT, Mar 13, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Illumina, Inc. - Common Stock

< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health 
Via News Direct
Exposures COVID-19
What We Learned About Genetic Sequencing During COVID-19 Could Revolutionize Public Health
SOURCE: Illumina 
Via 3BL Media
Exposures COVID-19
Illumina Celebrates National Intern Day
Illumina Celebrates National Intern Day 
Via News Direct
Illumina Celebrates National Intern Day
SOURCE: Illumina 
Via 3BL Media
3 Things About Illumina That Smart Investors Know
The company is cemented as the industry leader, but a crack is showing. 
Via The Motley Fool
After Naming a New CFO, Is This Genetic Diagnostics Company a Buy?
Veracyte appointed Rebecca Chambers, who boasts a wealth of financial executive experience, to the position. 
Via The Motley Fool
Illumina to Webcast Upcoming Investor Conference
From Illumina, Inc.
Via Business Wire
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance 
Via News Direct
Illumina Employees are Encouraged to Invest in Themselves With Annual Health and Lifestyle Allowance
SOURCE: Illumina 
Via 3BL Media
Illumina-Grail $8B Merger Hit By European Commission's In-Depth Investigation
The European Commission has opened an in-depth, three-month investigation into Illumina Inc's (NASDAQ: ILMN) planned takeover of Grail, a deal valued... 
Via Benzinga
The Branford Group to Conduct Auction of Leading Genomic Testing Lab CQuentia in Memphis
The Branford Group ("Branford"), a leader in asset valuation and disposition services, has been engaged by CQuentia to sell the assets of its genomic testing and personalized healthcare facility in... 
Via Newswire.com
Topics Intellectual Property
Exposures Intellectual Property
Illumina is Committed to Bringing Lifesaving GRAIL Test to People Globally as European Review Process Enters Second Phase
From Illumina, Inc.
Via Business Wire
The Vaccination of an Entire City in Brazil
How the Butantan Institute helped vaccinate the city of Serrana—and what they learned thereafter 
Via News Direct
Topics Death
Exposures COVID-19 Death
The Vaccination of an Entire City in Brazil
SOURCE: Illumina 
Via 3BL Media
Topics Death
Exposures COVID-19 Death
Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000
Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000 
Via News Direct
Illumina Wins Reddot 2021 Award: Genomic Sequencing System NextSeq 1000/2000
SOURCE: Illumina 
Via 3BL Media
Delta Defeats Bulls
Stocks tended to crash without rhyme or reason. 
Via Talk Markets
Best And Worst Performances Of The Week
Last week saw US indexes fall along with those of many European countries. However, Japan, Hong Kong, and Chinese markets all rose. 
Via Talk Markets
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings 
Via News Direct
Illumina Partners With Arab Health in Neonatal and Pediatric Intensive Care Settings
SOURCE: Illumina 
Via 3BL Media
Apple And Qualcomm Lead The QQQ Higher Wednesday
U.S. indices were trading higher Wednesday as investors weigh comments from Fed Chair Powell. Strength in Apple Inc (NASDAQ: 
Via Benzinga
Topics Economy
Exposures Interest Rates
Illumina, Grail Merger Faces Full-Scale European Probe Amid Antitrust Concerns: Reuters
The proposed $8 billion merger between liquid biopsy firm Grail Inc and cancer blood screening firm Illumina Inc (NASDAQ: ILMN) has met with nothing but flack... 
Via Benzinga
Is Illumina a Buy?
Illumina has gained almost 29% this year and could be headed higher. 
Via The Motley Fool
Bioinformatics Services Market Worth $5.3 Billion by 2026 - Exclusive Report by MarketsandMarkets™
The bioinformatics services market is projected to reach $5.3 Billion by 2026. Bioinformatics analysis market report provides crucial industry insights that will help your business grow. 
Via SBWire
Illumina to Announce Second Quarter 2021 Financial Results on Thursday, August 5, 2021
From Illumina, Inc.
Via Business Wire
Revolutionizing Forensics with Illumina’s Next-Generation Sequencing Technology
Othram, Inc. and the NovaSeq help convert more cases from cold to solved 
Via News Direct
Topics Death
Exposures Criminal Death Legal
Revolutionizing Forensics with Illumina’s Next-Generation Sequencing Technology
SOURCE: Illumina 
Via 3BL Media
Topics Death
Exposures Criminal Death Legal
3 Large-Cap Growth Stocks to Add to Your Portfolio This Summer
Even though investors rotated away from expensive growth stocks earlier this year, select growth stocks have been experiencing strong rebounds and in some instances are making new highs. 
Via Talk Markets
Why Illumina Was Up 17% in June
The company's liquid-biopsy spinoff can reportedly detect early-stage cancer in blood samples. 
Via The Motley Fool
Illumina and LetsGetChecked Collaborate on Surveillance Projects to Detect Covid-19 Variants
SOURCE: Illumina 
Via 3BL Media
Exposures COVID-19
< Previous 1 2
...
25 26 27 28 29 30 31 32 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.